|
gptkbp:instanceOf
|
gptkb:live_attenuated_vaccine
gptkb:vaccine
|
|
gptkbp:abbreviation
|
gptkb:BCG
|
|
gptkbp:administeredBy
|
intradermal injection
|
|
gptkbp:ATCCode
|
gptkb:J07AN01
|
|
gptkbp:broadcastOn
|
usually given at birth
|
|
gptkbp:category
|
bacteriology
immunology
oncology
|
|
gptkbp:compatibleWith
|
gptkb:United_States_(routine_vaccination)
|
|
gptkbp:contains
|
gptkb:attenuated_Mycobacterium_bovis
|
|
gptkbp:contraindication
|
pregnancy
immunocompromised individuals
|
|
gptkbp:developedBy
|
gptkb:Camille_Guérin
gptkb:Albert_Calmette
1921
|
|
gptkbp:effect
|
variable
|
|
gptkbp:legalStatus
|
prescription only
|
|
gptkbp:namedAfter
|
gptkb:Camille_Guérin
gptkb:Albert_Calmette
|
|
gptkbp:routeOfAdministration
|
intradermal
|
|
gptkbp:sideEffect
|
lymphadenitis
ulcer at injection site
|
|
gptkbp:storage
|
2–8°C
|
|
gptkbp:usedFor
|
bladder cancer treatment
tuberculosis prevention
|
|
gptkbp:usedIn
|
countries with high TB prevalence
|
|
gptkbp:WHOModelListOfEssentialMedicines
|
true
|
|
gptkbp:bfsParent
|
gptkb:BC
|
|
gptkbp:bfsLayer
|
5
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
Bacillus Calmette–Guérin
|